基于注意力机制的新型MRI深度学习网络用于预测IDH突变型星形细胞瘤中CDKN2A/B纯合缺失状态
研究利用TCIA和TCGA的234例IDH突变型星形细胞瘤的多参数脑MRI及基因组信息,构建结合注意力机制的ResFN-Net(基于ResNet)和FN-Net(基于ConvNeXt)两套多序列网络,以CE-T1WI和T2WI预测CDKN2A/B纯合缺失状态。FN-Net平均交叉验证ACC为0.9236、AUC为0.9704;两网络所有序列组合中CE-T1WI+T2WI表现最佳。作者认为FN-Net有潜力成为无创表征CDKN2A/B以辅助个体化分级和治疗规划的工具。
要点
- CDKN2A/B纯合缺失是胶质瘤分级和预后判断的重要标志物。
- 基于ConvNeXt的FN-Net预测性能优于基于ResNet的ResFN-Net。
- CE-T1WI与T2WI联合是两网络所有序列组合中表现最佳的组合。
核心结论
- 基于ConvNeXt网络的FN-Net深度学习网络在预测IDH突变型星形细胞瘤CDKN2A/B纯合缺失状态方面取得了有前景的性能。
研究设计与样本
- 研究获取234例受试者(CDKN2A/B纯合缺失阳性111例、阴性123例)的多参数脑MRI数据及对应基因组信息,分别来自癌症影像档案(TCIA)和癌症基因组图谱(TCGA)。
诊断标准与关键数值
- ResFN-Net平均交叉验证准确率(ACC)为0.813,平均交叉验证曲线下面积(AUC)为0.8804。
- FN-Net平均交叉验证ACC为0.9236,平均交叉验证AUC为0.9704。
- 比较两网络(ResFN-Net与FN-Net)所有序列组合,CE-T1WI与T2WI的序列组合表现最佳,两网络的ACC和AUC分别为0.8244、0.8975和0.8971、0.9574。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop a high-accuracy MRI-based deep learning method for predicting cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) homozygous deletion status in isocitrate dehydrogenase (IDH)-mutant astrocytoma.
METHODS: Multiparametric brain MRI data and corresponding genomic information of 234 subjects (111 positives for CDKN2A/B homozygous deletion and 123 negatives for CDKN2A/B homozygous deletion) were obtained from The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA) respectively. Two independent multi-sequence networks (ResFN-Net and FN-Net) are built on the basis of ResNet and ConvNeXt network combined with attention mechanism to classify CDKN2A/B homozygous deletion status using MR images including contrast-enhanced T1-weighted imaging (CE-T1WI) and T2-weighted imaging (T2WI). The performance of the network is summarized by three-way cross-validation; ROC analysis is also performed.
RESULTS: The average cross-validation accuracy (ACC) of ResFN-Net is 0.813. The average cross-validation area under curve (AUC) of ResFN-Net is 0.8804. The average cross-validation ACC and AUC of FN-Net is 0.9236 and 0.9704, respectively. Comparing all sequence combinations of the two networks (ResFN-Net and FN-Net), the sequence combination of CE-T1WI and T2WI performed the best, and the ACC and AUC were 0.8244, 0.8975 and 0.8971, 0.9574, respectively.
CONCLUSIONS: The FN-Net deep learning networks based on ConvNeXt network achieved promising performance for predicting CDKN2A/B homozygous deletion status of IDH-mutant astrocytoma.
CLINICAL RELEVANCE STATEMENT: A novel deep learning network (FN-Net) based on preoperative MRI was developed to predict the CDKN2A/B homozygous deletion status. This network has the potential to be a practical tool for the noninvasive characterization of CDKN2A/B in glioma to support personalized classification and treatment planning.
KEY POINTS: • CDKN2A/B homozygous deletion status is an important marker for glioma grading and prognosis. • An MRI-based deep learning approach was developed to predict CDKN2A/B homozygous deletion status. • The predictive performance based on ConvNeXt network was better than that of ResNet network.
引用
- Zhang L, Wang R, Gao J, et al. A novel MRI-based deep learning networks combined with attention mechanism for predicting CDKN2A/B homozygous deletion status in IDH-mutant astrocytoma. Eur Radiol. 2023. PMID: 37553486. doi:10.1007/s00330-023-09944-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。